Angiotensin receptor blocker neprilysin inhibitors-Reference-Cited by-同舟云学术

Angiotensin receptor blocker neprilysin inhibitors

Published:2021-08-26 Issue:8 Volume:13 Page:325-339
ISSN:1949-8462
Container-title:World Journal of Cardiology
language:
Short-container-title:WJC

Author:

Usuda Daisuke,Higashikawa Toshihiro,Hotchi Yuta,Usami Kenki,Shimozawa Shintaro,Tokunaga Shungo,Osugi Ippei,Katou Risa,Ito Sakurako,Yoshizawa Toshihiko,Asako Suguru,Mishima Kentaro,Kondo Akihiko,Mizuno Keiko,Takami Hiroki,Komatsu Takayuki,Oba Jiro,Nomura Tomohisa,Sugita Manabu

Publisher

Baishideng Publishing Group Inc.

Subject

Cardiology and Cardiovascular Medicine

Reference57 articles.

1. The pathophysiology of heart failure

2. Heart Failure With Reduced Ejection Fraction

3. Pohar R, MacDougall D. Combination Use of Ivabradine with Sacubitril/Valsartan: A Review of Clinical Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Feb 13. CADTH Rapid Response Reports

4. Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials

5. Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies;Cells;2024-09-01

2. The long non-coding RNA NEAT1 regulates the transcriptional landscape of cardiomyocytes;2024-06-27

3. Sacubitril/Valsartan in Heart Failure Hospitalization: Two Pills a Day to Keep Hospitalizations Away?;Cureus;2023-04-09

4. Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study;International Journal of Cardiology;2023-01

5. LCZ696 (sacubitril/valsartan) protects against cyclophosphamide-induced nephrotoxicity in adult male rats: Up-regulation of Apelin-13/ACE2, miR-200, and down-regulation of TGF-β/SMAD 2/3 and miR-192;Life Sciences;2022-10